Cargando…
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Currently, an increasing number of diseases related to insulin resistance and obesity is an alarming problem worldwide. It is well-known that the above states can lead to the development of type 2 diabetes, hypertension, and cardiovascular diseases. An excessive amount of triacylglycerols (TAGs) in...
Autores principales: | Bielawiec, Patrycja, Harasim-Symbor, Ewa, Chabowski, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064444/ https://www.ncbi.nlm.nih.gov/pubmed/32194509 http://dx.doi.org/10.3389/fendo.2020.00114 |
Ejemplares similares
-
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2020) -
Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
por: Charytoniuk, Tomasz, et al.
Publicado: (2022) -
Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2021) -
Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023) -
How do phytocannabinoids affect cardiovascular health? An update on
the most common cardiovascular diseases
por: Dziemitko, Sylwia, et al.
Publicado: (2023)